BioArctic AB (publ) - Asset Resilience Ratio

Latest as of September 2025: 72.35%

BioArctic AB (publ) (BIOA-B) has an Asset Resilience Ratio of 72.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr1.88 Billion

≈ $202.53 Million USD Cash + Short-term Investments

Total Assets

Skr2.60 Billion

≈ $279.92 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how BioArctic AB (publ)'s Asset Resilience Ratio has changed over time. Check BIOA-B strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down BioArctic AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BIOA-B market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr1.10 Billion	42.47%
Short-term Investments	Skr777.36 Million	29.89%
Total Liquid Assets	Skr1.88 Billion	72.35%

Asset Resilience Insights

Very High Liquidity: BioArctic AB (publ) maintains exceptional liquid asset reserves at 72.35% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

BioArctic AB (publ) Industry Peers by Asset Resilience Ratio

Compare BioArctic AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for BioArctic AB (publ) (2017–2024)

The table below shows the annual Asset Resilience Ratio data for BioArctic AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	70.07%	Skr778.92 Million ≈ $83.82 Million	Skr1.11 Billion ≈ $119.63 Million	+27.91pp
2023-12-31	42.16%	Skr500.00 Million ≈ $53.81 Million	Skr1.19 Billion ≈ $127.64 Million	-52.35pp
2021-12-31	94.51%	Skr848.40 Million ≈ $91.30 Million	Skr897.73 Million ≈ $96.61 Million	-0.70pp
2020-12-31	95.20%	Skr999.94 Million ≈ $107.61 Million	Skr1.05 Billion ≈ $113.03 Million	+1.17pp
2019-12-31	94.04%	Skr1.11 Billion ≈ $119.75 Million	Skr1.18 Billion ≈ $127.35 Million	+28.19pp
2018-12-31	65.85%	Skr917.31 Million ≈ $98.72 Million	Skr1.39 Billion ≈ $149.91 Million	-31.51pp
2017-12-31	97.36%	Skr1.11 Billion ≈ $119.49 Million	Skr1.14 Billion ≈ $122.73 Million	--

pp = percentage points

About BioArctic AB (publ)

ST:BIOA-B Sweden Biotechnology

Market Cap

$2.60 Billion

Skr24.13 Billion SEK

Market Cap Rank

#5274 Global

#73 in Sweden

Share Price

Skr325.00

Change (1 day)

+0.62%

52-Week Range

Skr214.80 - Skr364.40

All Time High

Skr377.80